Phosphoinositide-specific phospholipase C (PLC) plays a crucial role in initiating the surface-mediated signal transduction by generating second messenger molecules, diacylglycerol, and inositol phosphates (see [ 1-41 for reviews). Results accumulated during the last few years clearly indicate that the response of phosphoinositide signalling to a specific stimulus varies depending on tissue and cell types, even when the tissues and cells contain an identical subtype receptor. The simplest explanation for the heterogeneous response is that the post-receptor components, G-protein and PLC, required for the phosphoinositide signalling are differently expressed in different cells. It is noteworthy that at least two types of G-proteins, pertussin-toxin-sensitive and -insensitive forms are involved in phosphoinositide signalling [5, 61 and that, as discussed below, a number of PLC isoforms exist in mammalian tissues. There are three possible patterns of coupling for a receptor to the post-receptor components. First, a receptor might couple to a unique G-protein which then interacts with multiple PLC enzymes. Secondly, a receptor might couple to a variety of G-proteins which are then faithfully coupled to a single PLC. Thirdly, a receptor might couple to a variety of PLC forms through several different G-proteins. Information available at the present time cannot differentiate one from the other.
A number of distinct PLCs have been purified from a variety of mammalian tissues [7] PLC-B,, PLC-y, and PLC-6, to distinguish them from other members possessing both common and unique structural domains as described later. Mounting evidence suggests that protein kinase C activation by phorbol ester or diacylglycerol attenuates receptor-coupled PLC activity, thus providing a negative feedback signal to limit the magnitude and duration of receptor signalling. There are also numerous examples of the hydrolysis of PtdIns(4,5)P2 being affected by protein kinase A. The possible targets of protein kinase C and protein kinase A action appear to include PLC-B, and PLC-y,, respectively [12, 131. Thus, in cells containing PLC-B,, PCL-y, and PLC-6,, the activation of protein kinase C selectively phosphorylated PLC-B, [ 121, whereas elevation of intracellular concentration of cyclic AMP caused phosphorylation of PLC-y,, but not PLC-B, and PLC-6, [ 131.
The four types of enzymes are quite dissimilar not only in molecular size but also in amino acid sequences. This lack of sequence similarity is consistent with the absence of immunological crossreactivity between the four enzymes. When the sequences of PLC-B,, PLC-y, and PLC-6, originally isolated from rat and bovine brains were compared, despite a low overall homology between the three enzymes, a significant sequence similarity was found in two regions, one of about 150 amino acids and the other of about 240 amino acids. The two domains, designated X and Y in Fig. 1 , were about 60% and 40% identical, respectively (the length of the Y-domain is wider than previously recognized 171). The two X-and Y-regions might constitute, In an attempt to find additional types of PLC, cDNAs from various tissues were screened by low stringency cross-hybridization with probes made from the conserved domains X or Y. Four new PLC-related cDNAs were cloned and sequenced [14] . [18] . PLC-y, and PLC-y, have high sequence identities in the N-terminal 300 amino acids and in the region of 400 amino acids inserted between domains X and Y. In the 400 amino acid insert between domains X and Y, the PLC-y, and PLC-7, isoforms contain three regions that are related in sequence to the limited portions of STC. The three regions are duplicates of SH, and SH3 (STC homology 2 and 3). These so-called 'SH, and SH,'
were first recognized as highly conserved regions in the regulatory domains of a number of nonreceptor tyrosine kinases. Therefore, PLC-y can be Volume 19 lntracellular Phospholipases structurally divided into three domains, X, Y, and SH (SH, plus SH,). PLC activity was clearly detected when SH was deleted, although the activity was reduced to 10-30% of control. However, deletion in either X-or Y-domain led to complete loss of activity. It appears, therefore, that X-and Y-, but not SH-domains are essential for PLC activity. Taking advantage of the fact that monoclonal and polyclonal antibodies specific to PLC-p,, PLC-y, and PLC-6, are available, we devised sensitive doubledeterminant tandem assays [ 181. Since assays strictly rely on the specific finding of two different antibodies to a PLC molecule, they would be highly specific to each isoform. The antibodies used in these assays bind a PLC of the same isoform independently of species. Monoclonal antibodies specific to other isoforms such as PLC-p,, PLC-y2 and PLC-6, are not available yet. The results of immunoassays obtained with a variety of rat tissues and cultured cells are summarized in Table 1 .
PLC-p1 is highest in forebrain and exists in low quantities in most other tissues. In brain, PLC-PI was found to be highly localized in certain neurons when studied further by immunohistochemical methods. But most cultured cells, including neuron-like cells, also exhibited low levels of PLC-pI expression. PLC-y, showed a more widespread distribution, as we failed to detect any tissues or cells not containing this isoform. PLC-6, is also widely distributed in tissues, but exhibits limited expression in cultured cells. In brain, PLC-6, is highly localized in astroglial cells. Most importantly, a single type of cell contains more than one PLC isoform despite the similar catalytic properties of different PLC isoforms. This observation together with the fact that the PLC isoforms are significantly dissimilar in amino acid sequence suggests that there are different means of regulation for the isoforms. Thus, different modes of modulation may account in part for the diversity of responses observed in different tissues and individual cell types to a variety of external stimuli.
There is growing evidence that the mode of PLC activation initiated by platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) is different from that initiated by G-protein-coupled receptors [ 19-2 11. The observed differences include whether the mitogen-dependent PtdIns-(4,5)P2 hydrolysis exhibits a lag period after receptor stimulation, is inhibited by prior treatment with phorbol 12-myristate 13-acetate (PMA), and more importantly is activated by GTP or GTP analogues.
PDGF, vasopressin, and bombesin are potent mitogens for Swiss 3T3 cells, a rat fibroblast cell In another extensive study with rat liver epithelial WB cells, Hepler et al. [21] provided evidence that the EGF receptor and receptors for adrenaline, angiotensin I1 and [Arg8]vasopressin stimulate PtdIns(4,5)P2 hydrolysis by independent pathways. The time courses for accumulation of inositol phosphates in response to angiotensin I1 and EGF were markedly different. Whereas angiotensin I1 stimulated a very rapid accumulation of inositol phosphates (maximal by 30 s), increases in the levels of inositol phosphates in response to EGF were measurable only after a 30 s lag period; maximal levels were attained by 7-8 min. Under experimental conditions in which agonist-induced desensitization no longer occurred in these cells, the inositol phosphate responses to EGF and angiotensin I1 were additive, whereas those to angiotensin I1 and [Arg8]vasopressin were not additive. In crude WB lysates, angiotensin 11, [Arg*]vasopressin and adrenaline, each stimulated inositol phosphate formation in a guanine-nucleotide-dependent manner. In contrast, EGF failed to stimulate inositol phosphate formation in WB lysates in the presence or absence of GTP[S], even though EGF retained the capacity to bind to and stimulate tyrosine phosphorylation of its own receptor.
The results obtained with WFB cells [ZO] , Swiss 3T3 cells [19] and WB cells [Zl] , demonstrate that receptors for bombesin, adrenaline, Preparation of samples; rat tissues and cell lines were homogenized in the extraction buffer [SO mM-Tris/HCI, pH 7.6, I mM-EGTA, I % (v/v) Triton X-100, 2 mM-phenylmethanesulphonylfluoride, 0. I mn-dithiothreitol, and 2 p g of leupeptin/ml] with polytron (tissues; 10 s, three times) or sonicator (cell lines; 10 s, three times) and centrifuged in a tabletop microcentrifuge. The supernatants were used for the determination of protein concentration and the double-determinant tandem radioimmunoassay. Double-determinant tandem immunoassay: the principle of this assay is that binding of a horseradish peroxidase (HRP)-conjugated secondary antibody to the antigen immobilized by a primary antibody at a distinctive binding site is proportional to the amount of antigen present. Previously, we have shown that anti-PLC-y, monoclonal antibodies, F-7-2 and D-7-3, and anti-PLC-d, monoclonal antibodies, 2-78-5 and S-l 1-2, recognize different determinants on PLC-y, and PLC-d,, respectively [ 181. These pairs of monoclonal antibodies were used for the direct imrnunoassays for PLC isoenzymes. Since the amounts of PLC-p, in most tissues and cells are extremely low, it was necessary to improve the sensitivity of the assay by using rabbit polyclonal antibodies as the secondary antibody. Unlabelled monoclonal antibodies (PLC-/I, K-32-2 PLC-y, F-7-2 PLC-6, 2-78-5) were bound to the bottom of each startube (NuncImmunotube) by adding 200 pl of antibody solution to each tube (20 ,ug/ml in 30 mn-sodium carbonate buffer, pH 9.6) and incubated overnight at 4°C. The tubes were washed twice with PBS (phosphate-buffered saline). The remaining sites for protein binding on the tube were saturated by incubating with blocking buffer [300 pl of I% (w/v) BSNPBS, each tube) for 30 min at room temperature.
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The tubes were washed twice with PBS and 200 pl of sample or purified titred enzyme solution were added to the tubes and incubated for 2 h at 37°C in a humid atmosphere. The tubes were washed three times with PBS and 200 pl of secondary antibodies (PLC-p, and PLC-p, polyclonal antibody, I/lOooO diluted in I% BSNPBS PLC-y,, HRP-labelled purified D-7-3, 1/100 diluted in 5% BSNPBS with 0.02% Tween; PLC-6,, HPR-labelled purified S-I 1-2, 1/100 diluted in 5% BSNPBS with 0.02% Tween) were added and the tubes incubated for 2 h at 37°C in a humid atmosphere. In the case of PLC-j?,, after washing the secondary antibody solution with PBS, 200 pI of HRP-labelled goat anti-rabbit IgG (I/lOooO diluted in 5% BSNPBS with 0.02% Tween) were added and the tubes were incubated for 2 h at 37' C in a humid atmosphere. After incubation with HRP-labelled antibodies, the tubes were washed with 0.02% Tween 2O/PBS (twice) and PBS (three times) and 200 pl of substrate solution (2 mg of 0-phenylenediamine dihydrochloride/ml, 0.02% hydrogen peroxide, 0.03 M-citrate, 0.07 M-phosphate, pH 5.3) were added. After reaction (PLC-p,, 20 min; PLC-y,, 3.5 min; PLC-d,, 25 min, at room temperature), I ml of I N-H~SO~ was added to the tubes and the absorbance was read at 492 nm.
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PLC (ng/mg protein) angiotensin I1 and [Arg']vasopressin are apparently coupled to activation of PLC by as yet unidentified G-proteins. In contrast, a G-protein appears not to be involved in EGF and PDGF receptor actions in these cells. Recent evidence suggests that the growth factor receptors stimulate PtdIns(4,5)P2 hydrolysis, perhaps as a result of their capacity to stimulate tyrosine phosphorylation of PLC-I/,
